Lamya Rezig
Eit Health Expert @Eit Health
Signup · Get unlimited contacts
WORK HISTORY
Eit Health Expert @Eit Health
EIT Health is Europe’s leading platform for health innovation, venture development, and strategic partnerships across HealthTech, MedTech, and Longevity.Within this framework, the role focuses on the structuring and acceleration of high-growth ventures, the development of investment-ready projects, and the facilitation of strategic transactions between startups, investors, corporates, and institutional partners.Key areas include:Venture sourcing, evaluation, and portfolio development,Investment and partnership structuring,Corporate and institutional collaborations,Market access and international expansion,Public-private partnership initiatives.The position operates at the intersection of innovation, capital, and healthcare systems, with a strong focus on scalable value creation and long-term returns.Open to strategic partnerships, co-investments, and platform-level collaborations.
EDUCATION
Harvard Business School
𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝘀𝗵𝗶𝗽 𝗶𝗻 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗘𝗰𝗼𝗻𝗼𝗺𝗶𝗲𝘀
Aix-Marseille University
Master's Degree 2, Chemistry, Informatic, Data Processing, Spectroscopy and Analysis
Université Claude Bernard Lyon 1
Master's Degree 2, Pharmacology and Therapeutic Innovation
SDA Bocconi
Private Equity & Venture Capital
Harvard Business School
Technology Entrepreneurship: Lab to Market
Aix-Marseille University
Doctor of Philosophy (PhD), Analytical Chemistry
ABOUT LAMYA REZIG
Most life science, healthtech, and deeptech deals look compelling on paper.Breakthrough science. Credible teams. Massive TAMs.Many still fail not because the science breaks, but because reality does.Dr. Lamya Rezig works at the intersection of scientific uncertainty, capital deployment, and governance advising investors and boards decide how much risk is worth funding, and for how long.PhD with 10+ years across research, Big Pharma strategy (Sanofi, Merck, Bayer), and the medical device industry (bioMérieux). She has seen technologies succeed, stall, and fail and understands why timing, cost, and structure matter as much as innovation.She has built and led international innovation platforms across continents, evaluated hundreds of ventures, and advised founders, executives, and investors on high-stakes decisions involving capital allocation, partnerships, and strategic inflection points.Trained in private equity and venture capital (SDA Bocconi, Harvard Business School), fluent in four languages, and experienced in cross-border investment environments.Regular speaker at international investment and innovation events.Dr. Lamya Rezig is typically engaged before significant capital is committed, or when boards need an independent perspective on scientific risk, burn, and decision timing.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.